Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
Clinical trial NCT04539041 · COMPLETED
Trial details
- NCT number
- NCT04539041
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2024-10-17
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.